Retrospective Cohort Study
Copyright ©The Author(s) 2020.
World J Gastroenterol. Mar 21, 2020; 26(11): 1172-1184
Published online Mar 21, 2020. doi: 10.3748/wjg.v26.i11.1172
Table 2 Risk factors for morbidity after minimally invasive gastrectomy, n = 1401
FactorsUnivariate analysis, OR (95%CI)P valueMultivariate analysis, OR (95%CI)P value
Non-robotic minimally invasive surgery2.438 (1.381–4.304)0.0022.591 (1.418–4.717)0.002
Age ≥ 70 yr1.020 (0.706–1.474)0.920
Male2.277 (1.372–3.779)0.0011.969 (1.142–3.390)0.015
Body mass index ≥ 23 kg/m21.138 (0.763–1.698)0.538
ASA score 2 or higher1.069 (0.703–1.625)0.832
cT21 or higher1.296 (0.870–1.930)0.222
cN1 positive1.183 (0.745–1.879)0.540
cStage II1 or higher1.649 (1.102–2.467)0.0171.247 (0.809–1.922)0.318
Proximal or total gastrectomy1.847 (1.230–2.772)0.0041.208 (0.753–1.937)0.433
D2 lymph node dissection1.204 (0.809–1.792)0.415
Splenectomy2.734 (1.179–6.339)0.0261.360 (0.542–3.408)0.512
History of laparotomy1.083 (0.658–1.783)0.795
Operative time ≥ 360 min2.449 (1.613–3.718)< 0.0011.800 (1.098–2.952)0.020
Estimated blood loss ≥ 50 mL2.039 (1.367–3.042)< 0.0011.368 (0.873–2.143)0.209
Tumor size ≥ 30 mm1.119 (0.703–1.782)0.721
pT21 or higher1.378 (0.926–2.052)0.125
pN1 positive1.155 (0.761–1.753)0.516
pStage II 1 or higher1.471 (0.987–2.192)0.061
Use of neoadjuvant chemotherapy1.274 (0.662–2.452)0.467
Non-qualified surgeons1.148 (0.785–1.679)0.521